GOLDMAN SACHS GROUP INC Insider Trading -- Recent SEC Form 4 Transactions

GOLDMAN SACHS GROUP INC (CIK 886982) reported 104 SEC Form 4 insider transactions across 6 companies over the past 18 months (most recent 2026-08-13). Recent activity: Buy ATTO (85,000 shares), Sell ATTO (700 shares), Sell ATTO (447 shares), Sell ATTO (1,332 shares), Sell ATTO (200 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2026-08-13Attovia Therapeutics, Inc. (ATTO)InsiderBuy85,000$1.8M
2026-08-13Attovia Therapeutics, Inc. (ATTO)InsiderSell700$15,449
2026-08-13Attovia Therapeutics, Inc. (ATTO)InsiderSell447$9,776
2026-08-13Attovia Therapeutics, Inc. (ATTO)InsiderSell1,332$29,344
2026-08-13Attovia Therapeutics, Inc. (ATTO)InsiderSell200$4,410
2026-08-13Attovia Therapeutics, Inc. (ATTO)InsiderSell1,556$34,325
2026-08-13Attovia Therapeutics, Inc. (ATTO)InsiderSell3,402$74,912
2026-08-13Attovia Therapeutics, Inc. (ATTO)InsiderSell988$21,766
2026-08-13Attovia Therapeutics, Inc. (ATTO)InsiderSell480$10,344
2026-08-13Attovia Therapeutics, Inc. (ATTO)InsiderSell100$2,211
2026-08-13Attovia Therapeutics, Inc. (ATTO)InsiderSell753$16,543
2026-08-13Attovia Therapeutics, Inc. (ATTO)InsiderSell672$14,797
2026-08-13Attovia Therapeutics, Inc. (ATTO)InsiderSell6,970$153,549
2026-08-13Attovia Therapeutics, Inc. (ATTO)InsiderSell400$8,808
2026-08-13Attovia Therapeutics, Inc. (ATTO)InsiderSell1,180$25,771
2026-08-13Attovia Therapeutics, Inc. (ATTO)InsiderSell1,040$22,932
2026-08-13Attovia Therapeutics, Inc. (ATTO)InsiderSell300$6,252
2026-08-13Attovia Therapeutics, Inc. (ATTO)InsiderSell443$9,649
2026-08-13Attovia Therapeutics, Inc. (ATTO)InsiderSell200$4,410
2026-08-13Attovia Therapeutics, Inc. (ATTO)InsiderBuy2.0M$0
2026-08-13Attovia Therapeutics, Inc. (ATTO)InsiderSell1,163$25,807
2026-08-13Attovia Therapeutics, Inc. (ATTO)InsiderSell100$2,199
2026-08-13Attovia Therapeutics, Inc. (ATTO)InsiderSell6,763$146,148
2026-08-13Attovia Therapeutics, Inc. (ATTO)InsiderSell76,418$1.6M
2026-08-13Attovia Therapeutics, Inc. (ATTO)InsiderSell200$4,420

Source: SEC Form 4 filings · as of 2026-08-13